Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.9B | 23.8B | 21.9B | 21.7B |
Cost of revenue | 20.5B | 22.5B | 21.2B | 20.3B |
Gross profit | 1.5B | 1.3B | 710.4M | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.7B | 1.7B | 1.5B | 1.6B |
Operating income | -234.1M | -393.1M | -740.0M | -223.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 337.1M | 333.2M | 305.4M | 282.2M |
Other income expense | — | — | — | — |
Pretax income | 717.2M | 238.1M | 86.2M | 529.8M |
Tax provision | -8.4M | -11.8M | -15.8M | -13.8M |
Net income | 725.6M | 249.9M | 102.0M | 543.6M |
Basic EPS | — | 0.3 | 0.1 | 0.7 |
Diluted EPS | — | 0.3 | 0.1 | 0.7 |
Basic average shares | — | 734.9M | 728.9M | 734.6M |
Diluted average shares | — | 757.2M | 784.9M | 755.0M |
EBITDA | 1.1B | 571.3M | 391.6M | 863.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |